Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437.
Journal
ACS chemical biology
ISSN: 1554-8937
Titre abrégé: ACS Chem Biol
Pays: United States
ID NLM: 101282906
Informations de publication
Date de publication:
20 05 2022
20 05 2022
Historique:
pubmed:
29
4
2022
medline:
24
5
2022
entrez:
28
4
2022
Statut:
ppublish
Résumé
Anandamide or
Identifiants
pubmed: 35482948
doi: 10.1021/acschembio.2c00122
pmc: PMC9127799
doi:
Substances chimiques
Arachidonic Acids
0
Endocannabinoids
0
Polyunsaturated Alkamides
0
anandamide
UR5G69TJKH
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1174-1183Références
Life Sci. 2005 Aug 19;77(14):1584-604
pubmed: 15979096
Nat Rev Drug Discov. 2004 Sep;3(9):771-84
pubmed: 15340387
ACS Chem Biol. 2016 May 20;11(5):1245-54
pubmed: 26863403
Nature. 1996 Nov 7;384(6604):83-7
pubmed: 8900284
Neuroscience. 2012 Mar 1;204:207-29
pubmed: 22123166
Exp Eye Res. 2020 Dec;201:108266
pubmed: 32979397
Trends Pharmacol Sci. 2007 Apr;28(4):180-7
pubmed: 17350694
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3193-200
pubmed: 23108539
Front Mol Neurosci. 2017 May 29;10:166
pubmed: 28611591
FEBS J. 2013 May;280(9):1918-43
pubmed: 23551849
J Am Chem Soc. 2018 May 16;140(19):6067-6075
pubmed: 29420021
Biochem Pharmacol. 2003 May 1;65(9):1473-81
pubmed: 12732359
Vitam Horm. 2015;98:441-85
pubmed: 25817877
Annu Rev Psychol. 2013;64:21-47
pubmed: 22804774
Br J Pharmacol. 2012 Sep;167(2):313-23
pubmed: 22612332
Curr Top Microbiol Immunol. 2019;420:283-319
pubmed: 30242513
ACS Pharmacol Transl Sci. 2021 Mar 26;4(2):765-779
pubmed: 33860200
Science. 1997 Aug 22;277(5329):1094-7
pubmed: 9262477
Biochem Pharmacol. 2011 Jan 1;81(1):144-56
pubmed: 20858461
Chem Biol. 2009 Jun 26;16(6):624-32
pubmed: 19481477
Hypertension. 2008 Oct;52(4):601-7
pubmed: 18779440
Chem Sci. 2021 May 18;12(24):8288-8310
pubmed: 34221311
Front Chem. 2021 Apr 15;9:644811
pubmed: 33937194
Pharmacol Rev. 2006 Sep;58(3):389-462
pubmed: 16968947
J Med Chem. 2003 Apr 10;46(8):1512-22
pubmed: 12672252
FEBS Lett. 2000 Feb 25;468(2-3):176-80
pubmed: 10692582
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4269-74
pubmed: 12655057
Br J Pharmacol. 2008 Jan;153(2):319-34
pubmed: 17994113
Front Mol Neurosci. 2018 May 28;11:180
pubmed: 29910713
Nat Neurosci. 2011 Nov 20;15(1):64-9
pubmed: 22101642
CNS Neurol Disord Drug Targets. 2009 Dec;8(6):403-21
pubmed: 19839937
FEBS Lett. 2000 Oct 13;483(1):52-6
pubmed: 11033355
Prog Lipid Res. 2011 Apr;50(2):193-211
pubmed: 21295074
Nat Rev Immunol. 2005 May;5(5):400-11
pubmed: 15864274
Chem Soc Rev. 2010 Apr;39(4):1302-15
pubmed: 20309487
J Biol Chem. 2006 Apr 7;281(14):9066-75
pubmed: 16461355
J Lipid Res. 2008 Jun;49(6):1216-23
pubmed: 18316795
Proc Natl Acad Sci U S A. 2017 Jun 20;114(25):E5006-E5015
pubmed: 28584105
Front Pharmacol. 2016 Oct 13;7:370
pubmed: 27790143
Trends Pharmacol Sci. 2012 Jun;33(6):331-40
pubmed: 22503477
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
Angew Chem Int Ed Engl. 2013 Nov 11;52(46):12081-5
pubmed: 24173880
Front Mol Neurosci. 2019 Nov 26;12:286
pubmed: 31849602
Trends Pharmacol Sci. 2012 Apr;33(4):181-5
pubmed: 22297258
Traffic. 2015 Dec;16(12):1306-17
pubmed: 26394711
Angew Chem Int Ed Engl. 2013 Aug 12;52(33):8551-6
pubmed: 23754342
Nat Protoc. 2018 Apr;13(4):752-767
pubmed: 29565900
Chem Phys Lipids. 2005 Apr;134(2):131-9
pubmed: 15784231
Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6375-80
pubmed: 19307565